{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:16:57Z","timestamp":1779247017224,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31772739"],"award-info":[{"award-number":["31772739"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The National Key R & D Program of China","award":["2017YFD0502205"],"award-info":[{"award-number":["2017YFD0502205"]}]},{"name":"The National Key R & D Program of China","award":["2017YFD0502306"],"award-info":[{"award-number":["2017YFD0502306"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Porcine epidemic diarrhea virus (PEDV) of the family\n                      <jats:italic>Coronaviridae<\/jats:italic>\n                      has caused substantial economic losses in the swine husbandry industry. There\u2019s currently no specific drug available for treatment of coronaviruses or PEDV.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>In the current study, we use coronavirus PEDV as a model to study antiviral agents. Briefly, a fusion inhibitor tHR2, recombinant lentivirus-delivered shRNAs targeted to conserved M and N sequences, homoharringtonine (HHT), and hydroxychloroquine (HCQ) were surveyed for their antiviral effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Treatment with HCQ at 50\u2009\u03bcM and HHT at 150\u2009nM reduced virus titer in TCID\n                      <jats:sub>50<\/jats:sub>\n                      by 30 and 3.5 fold respectively, and the combination reduced virus titer in TCID\n                      <jats:sub>50<\/jats:sub>\n                      by 200 fold.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our report demonstrates that the combination of HHT and HCQ exhibited higher antiviral activity than either HHT or HCQ exhibited. The information may contribute to the development of antiviral strategies effective in controlling PEDV infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12985-020-01342-w","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T10:47:12Z","timestamp":1591181232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Three kinds of treatment with Homoharringtonine, Hydroxychloroquine or shRNA and their combination against coronavirus PEDV in vitro"],"prefix":"10.1186","volume":"17","author":[{"given":"Cui-Cui","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,3]]},"reference":[{"key":"1342_CR1","first-page":"167","volume":"44","author":"D Song","year":"2012","unstructured":"Song D, Park B. Porcine epidemic diarrhoea virus: a comprehensive review of molecular epidemiology, diagnosis, and vaccines. V\u00edrus Genes. 2012;44:167\u201375.","journal-title":"V\u00edrus Genes"},{"key":"1342_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/1743-422X-9-195","volume":"9","author":"Y Pan","year":"2012","unstructured":"Pan Y, Tian X, Li W, Zhou Q, Wang D, Bi Y, et al. Isolation and characterization of a variant porcine epidemic diarrhea virus in China. Viral J. 2012;9:195.","journal-title":"Viral J"},{"key":"1342_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3201\/eid1801.111259","volume":"18","author":"RQ Sun","year":"2012","unstructured":"Sun RQ, Cai RJ, Chen YQ, Liang PS, Chen DK, Song CX. Outbreak of porcine epidemic diarrhea in suckling piglets, China. Emerg Infect Dis. 2012;18:161\u20133.","journal-title":"Emerg Infect Dis"},{"key":"1342_CR4","doi-asserted-by":"publisher","first-page":"39700","DOI":"10.1038\/srep39700","volume":"7","author":"D Shi","year":"2017","unstructured":"Shi D, Shi H, Sun D, Chen J, Zhang X, Wang X, et al. Nucleocapsid interacts with NP, and protects it from proteolytic cleavage, enhancing cell survival, and is involved in PEDV growth. Sci Rep. 2017;7:39700.","journal-title":"Sci Rep"},{"issue":"1","key":"1342_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11262-004-4583-z","volume":"30","author":"J Fan","year":"2005","unstructured":"Fan J, Li Y. Cloning and sequence analysis of the M gene of porcine epidemic diarrhea virus Ljb\/03. Virus Genes. 2005;30(1):69\u201373.","journal-title":"Virus Genes"},{"key":"1342_CR6","doi-asserted-by":"publisher","first-page":"5169","DOI":"10.3748\/wjg.v13.i39.5169","volume":"13","author":"Y Ma","year":"2007","unstructured":"Ma Y, Chan CY, He ML. RNA interference and antiviral therapy. World J Gastroenterol. 2007;13:5169\u201379.","journal-title":"World J Gastroenterol"},{"key":"1342_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/978-1-59745-379-0_12","volume":"478","author":"S Travella","year":"2009","unstructured":"Travella S, Keller B. Down-regulation of gene expression by RNA- induced gene silencing. Methods Mol Biol. 2009;478:185\u201399.","journal-title":"Methods Mol Biol"},{"issue":"6","key":"1342_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2017.03.004","volume":"142","author":"CC Li","year":"2017","unstructured":"Li CC, Dong HJ, Wang P, Meng W, Han SJ, Ning S, et al. Cellular protein GLTSCR2: a valuable target for the development of broad-spectrum antivirals. Antivir Res. 2017;142(6):1\u201311.","journal-title":"Antivir Res"},{"issue":"1","key":"1342_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.virusres.2009.12.012","volume":"149","author":"J Zhou","year":"2010","unstructured":"Zhou J, Huang F, Hua X, Cui L, Zhang W, Shen Y, et al. Inhibition of porcine transmissible gastroenteritis virus (TGEV) replication in mini-pigs by shRNA. Virus Res. 2010;149(1):51\u20135.","journal-title":"Virus Res"},{"issue":"1","key":"1342_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.antiviral.2004.09.005","volume":"65","author":"CJ Wu","year":"2005","unstructured":"Wu CJ, Huang HW, Liu CY, Hong CF, Chan YL. Inhibition of SARS-CoV replication by siRNA. Antiviral Res. 2005;65(1):45\u20138.","journal-title":"Antiviral Res"},{"key":"1342_CR11","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1146\/annurev.biochem.70.1.777","volume":"70","author":"DM Eckert","year":"2001","unstructured":"Eckert DM, Kim PS. Mechanisms of viral membrane fusion and its inhibition. Annu Rev Biochem. 2001;70:777\u2013810.","journal-title":"Annu Rev Biochem"},{"key":"1342_CR12","doi-asserted-by":"publisher","first-page":"26941","DOI":"10.1074\/jbc.M109.004416","volume":"284","author":"D Eggink","year":"2009","unstructured":"Eggink D, Langedijk JP, Bonvin AM, Deng Y, Lu M, Berkhout B, et al. Detailed mechanistic insights into HIV-1 sensitivity to three generations fusion inhibitors. J Biol Chem. 2009;284:26941\u201350.","journal-title":"J Biol Chem"},{"key":"1342_CR13","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.biocel.2008.08.039","volume":"4","author":"H Nishikawa","year":"2009","unstructured":"Nishikawa H, Nakamura S, Kodama E, Ito S, Kajiwara K, Izumi K, et al. Electrostatically constrained alpha-helical peptide inhibits replication of HIV-1 resistant to enfuvirtide. Int J Biochem Cell Biol. 2009;4:891\u20139.","journal-title":"Int J Biochem Cell Biol"},{"key":"1342_CR14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S0929-6646(10)60029-0","volume":"109","author":"C Pan","year":"2010","unstructured":"Pan C, Liu S, Jiang S. HIV-1 gp41 fusion intermediate: a target for HIV therapeutics. J Formos Med Assoc. 2010;109:94\u2013105.","journal-title":"J Formos Med Assoc"},{"key":"1342_CR15","doi-asserted-by":"publisher","first-page":"8801","DOI":"10.1128\/JVI.77.16.8801-8811.2003","volume":"77","author":"BJ Bosch","year":"2003","unstructured":"Bosch BJ, van der Zee R, de Haan CA, Rottier PJ. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol. 2003;77:8801\u201311.","journal-title":"J Virol"},{"issue":"24","key":"1342_CR16","doi-asserted-by":"publisher","first-page":"13134","DOI":"10.1128\/JVI.02433-13","volume":"87","author":"J Gao","year":"2013","unstructured":"Gao J, Lu G, Qi J, Wu Y, Deng Y, Geng H, et al. Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus. J Virol. 2013;87(24):13134\u201340.","journal-title":"J Virol"},{"key":"1342_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.virol.2011.05.001","volume":"416","author":"XJ Wang","year":"2011","unstructured":"Wang XJ, Li CG, Chi XJ, Wang M. Characterisation and evaluation of antiviral recombinant peptides based on the heptad repeat regions of NDV and IBV fusion glycoproteins. Virology. 2011;416:65\u201374.","journal-title":"Virology"},{"key":"1342_CR18","doi-asserted-by":"publisher","first-page":"9223","DOI":"10.1128\/JVI.01153-13","volume":"87","author":"CG Li","year":"2013","unstructured":"Li CG, Tang W, Chi XJ, Dong ZM, Wang XX, Wang XJ. Cholesterol tag at N-terminal of the relatively broad spectrum of fusion inhibitory-peptide targets earlier stage of fusion glycoprotein activation and increases peptide\u2019s antiviral potency in vivo. J Virol. 2013;87:9223\u201332.","journal-title":"J Virol"},{"key":"1342_CR19","first-page":"1","volume":"15","author":"H Zhou","year":"2018","unstructured":"Zhou H, Xu RZ, Gu Y, Shi PF, Qian S. Targeting of phospho-eIF4E by homoharringtonine eradicates a distinct subset of human acute myeloid leukemia. Leuk Lymphoma. 2018;15:1\u201313.","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"1342_CR20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3390\/v10110601","volume":"10","author":"HJ Dong","year":"2018","unstructured":"Dong HJ, Wang ZH, Meng W, Li CC, Hu YX, Zhou L, et al. The natural compound homoharringtonine presents broad antiviral activity in vitro and in vivo. Viruses. 2018;10(11):601.","journal-title":"Viruses"},{"issue":"3","key":"1342_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/v9030053","volume":"9","author":"X Guo","year":"2017","unstructured":"Guo X, Zhang M, Zhang X, Tan X, Guo H, Zeng W, et al. Porcine epidemic diarrhea virus induces autophagy to benefit its replication. Viruses. 2017;9(3):53.","journal-title":"Viruses"},{"issue":"3","key":"1342_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41419-018-0378-3","volume":"9","author":"TT Tang","year":"2018","unstructured":"Tang TT, Lv LL, Pan MM, Wen Y, Wang B, Li ZL, et al. Hydroxychloroquine attenuates renal ischemia\/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation. Cell Death Dis. 2018;9(3):351.","journal-title":"Cell Death Dis"},{"issue":"3","key":"1342_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1089\/jir.2014.0038","volume":"35","author":"LF Wang","year":"2015","unstructured":"Wang LF, Lin YS, Huang NC, Yu CY, Tsai WL, Chen JJ, et al. Hydroxychloroquine-inhibited dengue virus is associated with host defense machinery. J Interferon Cytokine Res. 2015;35(3):143\u201356.","journal-title":"J Interferon Cytokine Res"},{"issue":"12","key":"1342_CR24","doi-asserted-by":"publisher","first-page":"18132","DOI":"10.1021\/acsomega.8b01002","volume":"3","author":"A Kumar","year":"2018","unstructured":"Kumar A, Liang B, Aarthy M, Singh SK, Garg N, Mysorekar I, et al. Hydroxychloroquine inhibits Zika virus NS2B-NS3 protease. ACS Omega. 2018;3(12):18132\u201341.","journal-title":"ACS Omega"},{"key":"1342_CR25","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.bbrc.2004.11.128","volume":"326","author":"B Morgenstern","year":"2005","unstructured":"Morgenstern B, Michaelis M, Baer PC, Doerr HW, Cinatl J. Ribavirin and interferon-\u03b2 synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines. Biochem Biophys Res Commun. 2005;326:905\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"1342_CR26","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/infdis\/jiu504","volume":"211","author":"EA Stein","year":"2015","unstructured":"Stein EA, Pinkert S, Becher PM, Geisler A, Zeichhardt H, Klopfleisch R, et al. Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice. J Infect Dis. 2015;211(4):613\u201322.","journal-title":"J Infect Dis"},{"issue":"10","key":"1342_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2018.07.022","volume":"158","author":"E Branche","year":"2018","unstructured":"Branche E, Tang WW, Viramontes KM, Young MP, Sheets N, Joo Y, et al. Synergism between the tyrosine kinase inhibitor sunitinib and anti-TNF antibody protects against lethal dengue infection. Antivir Res. 2018;158(10):1\u201310.","journal-title":"Antivir Res"},{"key":"1342_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.antiviral.2013.02.011","volume":"98","author":"F Boutimah","year":"2013","unstructured":"Boutimah F, Eekels JJ, Liu YP, Berkhout B. Antiviral strategies combining antiretroviral drugs with RNAi-mediated attack on HIV-1 and cellular co-factors. Antivir Res. 2013;98:121\u20139.","journal-title":"Antivir Res"},{"issue":"15","key":"1342_CR29","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s40265-018-0983-6","volume":"78","author":"MH Sheridan","year":"2018","unstructured":"Sheridan MH. Patisiran: First Global Approval. Drug. 2018;78(15):1625\u201331.","journal-title":"Drug"},{"key":"1342_CR30","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.ymthe.2006.07.007","volume":"14","author":"O Ter Brake","year":"2006","unstructured":"Ter Brake O, Konstantinova P, Ceylan M, Berkhout B. Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol Ther. 2006;14:883\u201392.","journal-title":"Mol Ther"},{"key":"1342_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.antiviral.2008.05.009","volume":"80","author":"TM Hinton","year":"2008","unstructured":"Hinton TM, Doran TJ. Inhibition of chicken anaemia virus replication using multiple short-hairpin RNAs. Antivir Res. 2008;80:143\u20139.","journal-title":"Antivir Res"},{"key":"1342_CR32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2174\/1566524015666150630124300","volume":"15","author":"B Jain","year":"2015","unstructured":"Jain B, Jain A. Taming influenza virus: role of antisense technology. Curr Mol Med. 2015;15:433\u201345.","journal-title":"Curr Mol Med"},{"issue":"1","key":"1342_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jviromet.2012.01.010","volume":"181","author":"YF Xu","year":"2012","unstructured":"Xu YF, Shen HY, Zhao MQ, Chen LJ, Li YG, Liao M, et al. Adenovirus-vectored shRNAs targeted to the highly conserved regions of VP1 and 2B in tandem inhibits replication of foot-and-mouth disease virus both in vitro and in vivo. J Virol Methods. 2012;181(1):51\u20138.","journal-title":"J Virol Methods"},{"issue":"1","key":"1342_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.antiviral.2011.10.023","volume":"93","author":"K Achazi","year":"2012","unstructured":"Achazi K, Patel P, Paliwal R, Radoni\u0107 A, Niedrig M, Donoso-Mantke O. RNA interference inhibits replication of tick-borne encephalitis virus in vitro. Antivir Res. 2012;93(1):94\u2013100.","journal-title":"Antivir Res"},{"issue":"2","key":"1342_CR35","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s11262-015-1242-5","volume":"51","author":"H Shen","year":"2015","unstructured":"Shen H, Zhang C, Guo P, Liu Z, Zhang J. Effective inhibition of porcine epidemic diarrhea virus by RNA interference in vitro. Virus Genes. 2015;51(2):252\u20139.","journal-title":"Virus Genes"},{"key":"1342_CR36","doi-asserted-by":"publisher","first-page":"7523","DOI":"10.1128\/JVI.78.14.7523-7527.2004","volume":"78","author":"Z Wang","year":"2004","unstructured":"Wang Z, Ren L, Zhao X, et al. Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells. J Virol. 2004;78:7523.","journal-title":"J Virol"},{"key":"1342_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2017.11.021","volume":"150","author":"P Zhao","year":"2017","unstructured":"Zhao P, Wang B, Ji CM, Cong X, Wang M, Huang YW. Identification of a peptide derived from the heptad repeat 2 region of the porcine epidemic diarrhea virus (PEDV) spike glycoprotein that is capable of suppressing PEDV entry and inducing neutralizing antibodies. Antivir Res. 2017;150:1\u20138.","journal-title":"Antivir Res"},{"issue":"17\u201318","key":"1342_CR38","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.drudis.2013.05.011","volume":"18","author":"AA Kaspar","year":"2013","unstructured":"Kaspar AA, Reichert JM. Future directions for peptide therapeutics development. Drug Discov Today. 2013;18(17\u201318):807.","journal-title":"Drug Discov Today"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-020-01342-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-020-01342-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-020-01342-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T22:09:58Z","timestamp":1622671798000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-020-01342-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,3]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1342"],"URL":"https:\/\/doi.org\/10.1186\/s12985-020-01342-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.23990\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.23990\/v1","asserted-by":"object"}]},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,3]]},"assertion":[{"value":"13 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest. None of the authors of this article has a financial or personal relationship with other people or organizations that could inappropriately influence or bias the content of the paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}